Virano Therapeutics
PrivateLast Round
Grant
Oct 23, 2025
Company Overview
Virano Therapeutics is a biotechnology company that develops genetic immunomodulation products and combination therapies to treat solid tumors and genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Virano Therapeutics Comparables
Compare Virano Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SIRION Biotech | 73% | |
| Mediphage Bioceuticals | 72% | |
| Virica Biotech | 66% | |
Virano Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 23, 2025 | ||||
| Accelerator | Dec 3, 2024 | ||||
| Seed | Nov 20, 2023 |
Virano Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Bioscience Innovation Organization | Grant |
| Capital BioVentures | Accelerator, Seed |
| AyaWas Group | Seed |
| FACIT | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 491% MoM, from 32 to 189.
- Dec 3, 2024
Received funding from Capital BioVentures.
Virano Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Virano Therapeutics's valuation, stock price, and market status.